Panome Bio Inc
Publicly observedSaint Louis, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Saint Louis | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Panome Bio Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | D1WQKF3J33Q4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant2 Sept 2025Publicly observed
NIH SBIR/STTR award: Biomarker discovery in colon cancer through next-generation metabolomics
USD 1,164,167.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant2 Sept 2025Publicly observed
NIH SBIR/STTR award: Biomarker discovery in colon cancer through next-generation metabolomics
USD 881,647.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.